SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-043184
Filing Date
2023-05-26
Accepted
2023-05-25 17:38:26
Documents
13
Period of Report
2023-05-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea179301-8k_cadrenal.htm   iXBRL 8-K 28064
2 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT BY AND BETWEEN CADRENAL THERAPEUTICS, IN ea179301ex10-1_cadrenal.htm EX-10.1 9045
  Complete submission text file 0001213900-23-043184.txt   215714

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cvkd-20230525.xsd EX-101.SCH 3004
4 XBRL LABEL FILE cvkd-20230525_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE cvkd-20230525_pre.xml EX-101.PRE 22389
7 EXTRACTED XBRL INSTANCE DOCUMENT ea179301-8k_cadrenal_htm.xml XML 3715
Mailing Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Filer) CIK: 0001937993 (see all company filings)

IRS No.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41596 | Film No.: 23962210
SIC: 2834 Pharmaceutical Preparations